New inhibitors of fungal 17β-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold

References

• Adamski J, Jakob JF. A guide to 17β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2001; 171: 1–4
   PubMed Web of Science ®Google Scholar
• Mindnich R, Möller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2004; 218: 7–20
   PubMed Web of Science ®Google Scholar
• Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrinol Rev 1997; 18: 281–305
   PubMed Web of Science ®Google Scholar
• Penning TM, Ricigliano JW. Mechanism based inhibition of hydroxysteroid dehydrogenases. J Enz Inhib 1991; 5: 165–198
   Google Scholar
• Lukacik P, Kavanagh KL, Opperman U. Structure and function of human 17β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2006; 248: 61–71
   PubMed Web of Science ®Google Scholar
• Poirier D. Inhibitors of 17β-hydroxysteroid dehydrogenases. Curr Med Chem 2003; 10: 453–477
   PubMed Web of Science ®Google Scholar
• Le Lain R, Nicholls PJ, Smith HJ, Mahrlouie FH. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer. J Enz Inhib 2001; 16: 35–45
   Google Scholar
• Le Lain R, Barrell KJ, Saeed GS, Nicholls PJ, Simons C, Kirby A, Smith HJ. Some coumarins and triphenylethene derivatives as inhibitors of human testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD type 3): further studies with tamoxifen on the rat testes microsomal enzyme. J Enz Inhib 2002; 17: 93–100
   Google Scholar
• Le Bail JC, Pouget C, Fagnere C, Basly JP, Chulia AJ, Habrioux G. Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities. Life Sci 2001; 68: 751–761
   PubMed Web of Science ®Google Scholar
• Makela S, Poutanen M, Lehtimaki J, Kostian ML, Santii R, Vihko R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type I as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 1995; 208: 51–59
   PubMed Web of Science ®Google Scholar
• Makela S, Poutanen M, Kostian ML, Lehtimaki N, Strauss L, Santii R, Vihko R. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 1998; 217: 310–316
   PubMed Web of Science ®Google Scholar
• Krazeisen A, Breitling R, Moeller G, Adamski J. Phytoestrogens inhibit human 17β-hydroxysteroid dehydrogenase type 5. Mol Cell Endocrinol 2001; 171: 151–162
   PubMed Web of Science ®Google Scholar
• Krazeisen A, Breitling R, Moeller G, Adamski J. Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids. Adv Exp Med Biol 2002; 505: 151–161
   PubMed Web of Science ®Google Scholar
• Lanišnik Rižner T, Möller G, Thole HH, Žakelj-Mavrič M, Adamski J. A novel 17β-hydroxysteroid dehydrogenase in the fungus Cochliobolus lunatus: New insights into the evolution of the steroid-hormone signalling. Biochem J 1999; 337: 425–431
   PubMed Web of Science ®Google Scholar
• Kristan K, Lanišnik Rižner T, Stojan J, Gerber JK, Kremmer E, Adamski J. Significance of individual amino acid residues for coenzyme and substrate specificity of 17β-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus. Chem Biol Interact 2003; 143/144: 493–501
   Web of Science ®Google Scholar
• Kristan K, Krajnc K, Konc J, Gobec S, Stojan J, Lanišnik Rižner T. Phytoestrogens as inhibitors of fungal 17β-hydroxysteroid dehydrogenase. Steroids 2005; 70: 626–635
   PubMed Web of Science ®Google Scholar
• Gobec S, Sova M, Kristan K, Lanišnik Rižner T. Cinnamic acid esters as potent inhibitors of fungal 17β-hydroxysteroid dehydrogenase – a model enzyme of the short-chain dehydrogenase/reductase superfamily. Bioorg Med Chem Lett 2004; 14: 3933–3936
   PubMed Web of Science ®Google Scholar
• Kristan K, Starčević Š, Brunskole M, Lanišnik Rižner T, Gobec S. Cinnamates and Cinnamamides inhibit fungal 17β-hydroxysteroid dehydrogenase. Mol Cell Endocrinol 2006; 248: 239–241
   PubMed Web of Science ®Google Scholar
• Usami N, Yamamoto T, Shintani S, Higaki Y, Ishikura S, Katagiri Y, Hara A. Substrate specificity of human 3(20)α-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull 2002; 25: 441–445
   PubMed Web of Science ®Google Scholar
• Higaki Y, Usami N, Shintani S, Ishikura S, El-Kabbani O, Hara O. Selective and potent inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chem Biol Interact 2003; 143/144: 503–513
   Web of Science ®Google Scholar
• von Stahl PH, Barchet R, Merz KW. Umsetzungen von aromatischen und heterocyclischen o-Diaminen mit Äthoxymethylenemalonester und Äthoxymethylencyanessigester. Arzneimittelforschung 1968; 18: 1214–1219
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Ueda T. Preparation and hydrolysis of 4-amino-1H-1,5-benzodiazepine-3-carbonitrile. Chem Pharm Bull 1975; 23: 1391–1395
   Web of Science ®Google Scholar
• Lanišnik Rižner T, Adamski J, Stojan J. 17β-Hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: Model structure and substrate specificity. Arch Biochem Biophys 2000; 384: 255–262
   PubMed Web of Science ®Google Scholar
• Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 1998; 19: 1693–1662
   Web of Science ®Google Scholar
• Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner P. A new force-field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106: 765–784
   Web of Science ®Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity – a rapid access to atomic charges. Tetrahedron 1980; 36: 3219–3228
   Web of Science ®Google Scholar
• Mehler EL, Solmajer T. Electrostatic effects in proteins – comparison of dielectric and charge models. Protein Eng 1991; 4: 903–910
   PubMedGoogle Scholar